青島金王(002094.SZ):金王產業鏈擬出資2500萬元與安華生物設立子公司
格隆匯6月25日丨青島金王(002094.SZ)公吿,公司於2021年6月25日審議通過了《關於設立合資公司暨關聯交易的議案》,公司擬與山東安華生物醫藥股份有限公司(“安華生物”)共同設立子公司,其中公司全資子公司青島金王產業鏈管理有限公司(“金王產業鏈”)出資2500萬元,佔註冊資本的50%,安華生物出資2500萬元,佔註冊資本的50%。根據合同約定,金王產業鏈及安華生物各向子公司派三名董事,金王產業鏈擬派公司董事陳索斌擔任擬設立公司的董事。
安華生物是醫美、食品、化粧品等上游原料研發、生產及銷售透明質酸鈉的核心企業之一,擁有多項核心技術與獨家專利。隨着消費升級以及醫美滲透率的提升,醫美服務的供給端和需求端快速增長,醫美行業迎來快速發展階段,安華生物打算快速進入終端市場並打造品牌影響力。公司作為美粧及化粧品在國內擁有眾多渠道的銷售運營公司,可與安華生物進行優勢互補,快速提升雙方在醫美及化粧品行業中的市場競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.